Quarterly report [Sections 13 or 15(d)]

License Agreement (Details Narrative)

v3.25.4
License Agreement (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2021
May 31, 2020
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Jun. 30, 2025
LicenseAgreementLineItems [Line Items]              
Research and development expense     $ 1,164,737 $ 1,220,535 $ 1,974,728 $ 2,535,394  
Common stock, par value     $ 0.001   $ 0.001   $ 0.001
Vernalis Development Limited [Member]              
LicenseAgreementLineItems [Line Items]              
Research and development expense   $ 150,000          
Vernalis Development Limited [Member] | IPO [Member]              
LicenseAgreementLineItems [Line Items]              
Number of shares of common stock 192,857            
Common stock, par value $ 0.001            
Future milestone payments $ 1,400,000            
Vernalis Development Limited [Member] | Minimum [Member]              
LicenseAgreementLineItems [Line Items]              
Marketing authorization amount   400,000          
Sales milestone payments   10,000,000.0          
Cumulative annual net sales amount   500,000,000.0          
Vernalis Development Limited [Member] | Maximum [Member]              
LicenseAgreementLineItems [Line Items]              
Marketing authorization amount   3,000,000.0          
Development milestone payment   29,900,000          
Sales milestone payments   25,000,000.0          
Cumulative annual net sales amount   $ 1,000,000,000.0